Wells Fargo Upgrades Calumet Specialty Products Partners (CLMT) to Outperform

Wells Fargo upgraded Calumet Specialty Products Partners (NASDAQ: CLMT) from Market Perform to Outperform with a price target of $31-$35. The change follows meetings with management and recent declines in the stock. Analyst Roger D. Read has confidence in Calumet's sector-leading yield.

For an analyst ratings summary and ratings history on Calumet Specialty Products Partners click here. For more ratings news on Calumet Specialty Products Partners click here.

Shares of Calumet Specialty Products Partners closed at $26.67 yesterday.

You May Also Be Interested In

• Wells Fargo Upgrades Neurocrine Bio. (NBIX) to Overweight 'as the Company is Knocking on the Doors of the Large-Cap Club'
• Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
• Mizuho Upgrades Airbnb Inc. (ABNB) to Buy, 'We see opportunities'